2024 Archive

Profiles

5 Questions for J. Paul Taylor, MD, PhD

J. Paul Taylor, MD, PhD and Brian O'Flynn, PhD and Kristin Stephenson, MHA, JD

Learn how J. Paul Taylor, MD, PhD, leveraged the unique infrastructure at St. Jude to launch the Pediatric Translational Neuroscience Initiative

Research

Distinct molecular profiles lead to a better understanding of acute leukemia

Emilia Asante, PhD

Distinct molecular profiles in acute myeloid leukemia (AML) and T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LLy) with PICALM::MLLT10 (PM) fusions shed light on potential targeted therapies for improved outcomes.

Outreach

Global peer community sets standards to save vulnerable children from infectious diseases

Alex Generous, PhD

St. Jude is helping train and make guidelines to prevent and treat infections during pediatric cancer treatment worldwide.

Sickle Cell

Boot camp trains sickle cell disease ‘pain crises champions’ to improve patient care

Alex Generous, PhD

St. Jude and UTHSC are training nurses worldwide how to better care for people with sickle cell disease.

Research

A glimpse beyond life and death: Exploring the biology of the MICOS complex

Brian O'Flynn, PhD

See how new model offers glimpse into vital mitochondrial complex

Profiles

Core values underlie nursing excellence with Sarah Currie, RNC, MSN, NEA-BC

Sarah Currie, RNC, MSN, NEA-BC

Learn about the values that shape nursing research and care at St. Jude.

Survivorship

Addressing the needs of childhood cancer survivors

Brian O'Flynn, PhD

See how many factors from environment to genetics affect the post-treatment experience of childhood cancer survivors

HIV

Long-acting injectable HIV drugs safe for treating adolescents

Alex Generous, PhD

Learn how long-lasting drugs offer hope for adolescent with HIV.

Sickle Cell

Evaluating care for ‘the forgotten population’: Factors affecting sickle cell care

Kathryn J. McCullough, MA

St. Jude researchers examine factors that affect access to care for patients with sickle cell disease.

Respiratory Diseases

Influenza virus provides first evidence of bats’ potential as an intermediate host

Alex Generous, PhD

Explore research showing bats may be an intermediate influenza host.